Anticoagulation in COVID-19 patients requiring continuous renal replacement therapy - 09/06/21
Doi : 10.1016/j.accpm.2021.100841
Nizar Attallah a, b, ⁎ 
, Sudeendra Gupta a, Rakesh Madhyastha a, Wasim S. El Nekidy b, c, Jihad Mallat b, d
, Sudeendra Gupta a, Rakesh Madhyastha a, Wasim S. El Nekidy b, c, Jihad Mallat b, d a Department of Nephrology, Medical Subspecialties Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates
b Cleveland Clinic Lerner College of Medicine of Case Western University, Cleveland, Ohio, USA
c Department of Pharmacy
d Critical Care Institute, Cleveland Clinic Abu Dhabi, United Arab Emirates
⁎Corresponding author at: Department of Nephrology, Medical Subspecialties Institute, Cleveland Clinic Abu Dhabi, PO Box 112412, Al Maryah Island, Abu Dhabi, United Arab Emirates.Department of Nephrology, Medical Subspecialties Institute, Cleveland Clinic Abu DhabiPO Box 112412, Al Maryah IslandAbu DhabiUnited Arab Emirates
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.
Conéctese para beneficiarse!
Keywords : Acute kidney injury, Continuous renal replacement therapy, COVID-19 infection, Anticoagulation
El texto completo de este artículo está disponible en PDF.
Esquema
© 2021
Société française d'anesthésie et de réanimation (Sfar). Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Vol 40 - N° 3
Artículo 100841- juin 2021 Regresar al número
Artículo precedente
- Anesthesia care for coronavirus disease (COVID-19) patients: Results from a survey evaluating opinions of American Society of Anesthesiologists (ASA) members
- Ahmad Elsharydah, Ejike N. Okoro, C. Ikenna Nwafor, Laura J. Delin, David W. Mercier, Girish P. Joshi
- Diaphragmatic excursion: A possible key player for predicting successful weaning in patients with severe COVID-19
- Mina Adolf Helmy, Lydia Magdy Milad, Safinaz Hassan Osman, Mai Ahmed Ali, Ahmed Hasanin
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.